INSIGHTS ON CLINICAL TRIAL PARTNERING

• Investigator Payments – A Critical Component In Bayer’s Sponsor Of Choice Strategy

  Year after year, slow and unpredictable investigator payments continue to be a top complaint from clinical study sites. Explore Bayer's Automated Site Payment Invoice Resolution project in the available white paper.

• Virtual Site Audits Should Be The New Standard

  To keep life-saving drug launches on track during COVID-19, we had to start doing virtual site audits for the first time — and discovered an excellent business model in the process.

• Drug Repurposing Trends — A CDMO Perspective

  Dr. Anil Kane, Executive Director, Global Head of Technical & Scientific Affairs at Thermo Fisher Scientific, reviews drug repurposing trends and shares case studies to demonstrate how a CDMO plays a role in drug repurposing and supporting the pharmaceutical industry in taking drugs to market approval.

• How To Build Productive, Strategic Sponsor-CRO Partnerships

  The relationship between sponsors and CROs is strengthening as the outsourcing of trials becomes ever-more common. Watch the available webinar to see how it’s in both parties’ interests to align their goals, structures, and processes in order to increase productivity, reduce costs, and ultimately deliver more successful studies.

• Factoring The "What Ifs" Into Supply Forecasting

  8/24/2020

  Review considerations for developing a supply plan, the influence of early decisions and their impact on outcomes as a trial progresses, and how decisions can put patients and the trial at risk.

• Recipe For Success In Radiopharmaceutical studies

  3/7/2021

  Radiopharmaceutical (RP) studies are not your average clinical trial. With the RP space expanding, sponsors need a team with the experience it takes to turn their synopsis into a fully rounded protocol with the maximum chance of success.

• Conclusive & Positive Results Delivered Ahead Of Time – By Eight Months

  12/22/2020

  Most patients with Binge Eating Disorder (BED) seek help from psychiatrists, nutritionists, or obesity specialists, but there was no approved, effective pharmacologic treatment. With unanticipated interest in pivotal Phase 3 studies, we needed to line up and train the right resources while collaborating effectively with the central laboratory, data manager, and other participants.

• End-To-End Workflow: From Budget Creation To Payment Execution

  11/9/2020

  Join Greenphire's Catherine Click, Director, Clinical Pricing & Analysis, and Kyle Cunningham, Chief Product Officer as they discuss the four key budgeting challenges faced by sponsors and CROs which can hinder global study success.

• Compelling Advantages Of Creating A Patient-Centric Supply Chain

  1/1/2022

  Marken’s Nina Vas, discusses everything from global regulatory and trade compliance proficiency to the importance of a secure, closed-loop environment with regard to developing a patient-centric supply chain.